Cholesteatoma Fibroblasts Promote Epithelial Cell Proliferation through Overexpression of Epiregulin

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Yoshikawa, Mamoru ^a   Kojima, Hiromi ^b   Yaguchi, Yuichiro ^b   Okada, Naoko ^c   Saito, Hirohisa ^c   Moriyama, Hiroshi ^b  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIREGULIN; MESSENGER RNA;

ARTICLE; CELL PROLIFERATION; CHOLESTEATOMA; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; EPIREGULIN GENE; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; FIBROBLAST CULTURE; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MOLECULAR PATHOLOGY; PROTEIN EXPRESSION; SKIN FIBROBLAST; TUMOR PROMOTION;

BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLESTEATOMA; COCULTURE TECHNIQUES; DNA PRIMERS; EAR, MIDDLE; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84879477092     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066725     Document Type: Article

References (36)

1. Olszewska E, Wagner M, Bernal-Sprekelsen M, Ebmeyer J, Dazert S, et al. (2004) Etiopathogenesis of cholesteatoma. Eur Arch Otorhinolaryngol 261: 6-24.
2. Kojima H, Shiwa M, Kamide Y, Moriyama H, (1994) Expression and localization of mRNA for epidermal growth factor and epidermal growth factor receptor in human cholesteatoma. Acta Otolaryngol (Stockh) 114: 423-429.
3. Yamamoto-Fukuda T, Aoki D, Hishikawa Y, Kobayashi T, Takahashi H, et al. (2003) Possible involvement of keratinocyte growth factor and its receptor in enhanced epithelial cell proliferation and acquired recurrence of middle-ear cholesteatoma. Laboratory Invest 83: 123-136.
4. Maas-Szabowski N, Shimotoyodome A, Fusenig NE, (1999) Keratinocyte growth regulation in fibroblast cocultures via a double paracrine mechanism. J Cell Sci 112: 1843-1853.
5. Szabowski A, Maas-Szabowski N, Andrecht S, Kolbus A, Schorpp-Kistner M, et al. (2000) c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin. Cell 103: 745-755.
6. El Ghalbzouri A, Lamme E, Ponec M, (2002) Crucial role of fibroblasts in regulating epidermal morphogenesis. Cell Tiss Res 310: 189-199.
7. el-Ghalbzouri A, Gibbs S, Lamme E, Van Blitterswijk CA, Ponec M, (2002) Effect of fibroblasts on epidermal regeneration. British Journal of Dermatology 147: 230-243.
8. Werner S, Smola H, (2001) Paracrine regulation of keratinocyte proliferation and differentiation. Trends Cell Biol 11: 143-146.
9. Schilling V, Negri B, Bujia J, Schulz P, Kastenbauer E, (1992) Possible role of interleukin-1 alpha and interleukin-1 beta in the pathogenesis of cholesteatoma of the middle ear. Am J Otol 13: 350-355.
10. Yetiser S, Satar B, Aydin N, (2002) Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma. Otol Neurotol. 23: 647-652.
11. Chung JW, Yoon TH, (1998) Different production of interleukin-1alpha, interleukin-1beta and interleukin-8 from cholesteatomatous and normal epithelium. Acta Otolaryngol (Stockh) 118: 386-391.
12. Yoshikawa M, Kojima H, Wada K, Tsukidate T, Okada N, et al. (2006) Identification of specific gene expression profiles in fibroblasts derived from middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg 132: 734-742.
13. Elenius K, Paul S, Allison G, Sun J, Klagsbrun M, (1997) Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J 16: 1268-1278.
14. Riese DJ 2nd, Bermingham Y, van Raaij TM, Buckley S, Plowman GD, et al (1996) Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta. Oncogene 12: 345-353.
15. Komurasaki T, Toyoda H, Uchida D, Morimoto S, (1997) Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4. Oncogene 15: 2841-2848.
16. Shirakata Y, Kishimoto J, Tokumaru S, Yamasaki K, Hanakawa Y, et al. (2007) Epiregulin, a member of the EGF family, is over-expressed in psoriatic epidermis. J Dermatol Sci 45: 69-72.
17. Toyoda H, Komurasaki T, Uchida D, Takayama Y, Isobe T, et al. (1995) Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J Biol Chem 270: 7495-7500.
18. Pastore S, Mascia F, Mariani V, Girolomoni G, (2007) The epidermal growth factor receptor system in skin repair and inflammation. J Invest Dermatol 128: 1365-1374.
19. Lindvall C, Hou M, Komurasaki T, Zheng C, Henriksson M, et al. (2003) Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: activation of the epiregulin gene. Cancer Res 63: 1743-1747.
20. Yamamoto T, Akisue T, Marui T, Nakatani T, Kawamoto T, et al. (2004) Expression of betacellulin, heparin-binding epidermal growth factor and epiregulin in human malignant fibrous histiocytoma. Anticancer Res 24: 2007-2010.
21. Kojima H, Matsuhisa A, Shiwa M, Kamide Y, Nakamura M, et al. (1996) Expression of messenger RNA for keratinocyte growth factor in human cholesteatoma. Arch Otolaryngol Head Neck Surg 122: 157-160.
22. Ishibashi T, Shinogami M, Kaga K, Fukaya T, (1997) Keratinocyte growth factor and receptor mRNA expression in cholesteatoma of the middle ear. Acta Otolaryngol (Stockh) 117: 714-718.
23. Li XD, Miao SY, Wang GL, Yang L, Shu YQ, et al. (2010) Amphiregulin and epiregulin expression in colorectal carcinoma and the correlation with clinicopathological characteristics. Onkologie 33: 353-358.
24. Kuramochi H, Nakajima G, Kaneko Y, Nakamura A, Inoue Y, et al. (2012) Amphiregulin and epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases. BMC Cancer 12: 88.
25. Shirakata Y, Komurasaki T, Toyoda H, Hanakawa Y, Yamasaki K, et al. (2000) Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes. J Biol Chem 275: 5748-5753.
26. Roth M, Johnson PR, Borger P, Bihl MP, Rudiger JJ, et al. (2004) Dysfunctional interaction of C/EBPalpha and the glucocorticoid receptor in asthmatic bronchial smooth muscle cells. New Engl J Med 351: 560-574.
27. Sudhoff H, Dazert S, Gonzales AM, Borkowski G, Park SY, et al. (2000) Angiogenesis and angiogenic growth factors in middle ear cholesteatoma. Am J Otol 21: 793-798.
28. Inatomi O, Andoh A, Yagi Y, Bamba S, Tsujikawa T, et al. (2006) Regulation of amphiregulin and epiregulin expression in human colonic subepithelial myofibroblasts. Int J Mol Med 18: 497-503.
29. Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, et al. (2008) Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 68: 918-926.
30. Hawsawi NM, Ghebeh H, Hendrayani S-F, Tulbah A, Al-Eid M, et al. (2008) Breast carcinoma-associated fibroblasts and their counterparts display neoplastic-specific changes. Cancer Res 68: 2717-2725.
31. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, et al. (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348.
32. Koukourakis MI, Giatromanolaki A, Harris AL, Sivridis E, (2006) Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res 66: 632-637.
33. Kaminski A, Hahne JC, Haddouti el M, Florin A, Wellmann A, et al. (2006) Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts. Int J Mol Med 18: 941-950.
34. Li S, Takeuchi F, Wang JA, Fan Q, Komurasaki T, et al. (2008) Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas. Proc Natl Acad Sci USA 105: 3539-3544.
35. Arora A, Scholar EM, (2005) Role of tyrosine kinase inhibitors in cancer therapy. J Pharmacol Exp Ther 315: 971-979.
36. Sibilia M, Kroismayr R, Lichtenberger BM, Natarajan A, Hecking M, et al. (2007) The epidermal growth factor receptor: from development to tumorigenesis. Differentiation 75: 770-787.